ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Bowel & Cancer Research

Bowel & Cancer Research is an active company incorporated on 29 September 2006 with the registered office located in London, Greater London. Bowel & Cancer Research was registered 19 years ago.
Status
Active
Active since 17 years ago
Company No
05951118
Private Limited Company by guarantee without share capital, use of 'Limited' exemption
Age
19 years
Incorporated 29 September 2006
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 23 September 2025 (1 month ago)
Next confirmation dated 23 September 2026
Due by 7 October 2026 (11 months remaining)
Last change occurred 9 years ago
Accounts
Submitted
For period 1 Jan ⟶ 31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Learn more about Bowel & Cancer Research
Contact Update Details
Address
1st Floor Abernethy Building
2 Newark Street
London
E1 2AT
Same address for the past 10 years
Telephone
02078828749
Email
Available in Endole App
Website
Bandcr.org
See All Contacts
People
Officers
3
Shareholders
-
Controllers (PSC)
1
Ms Asha Senapati
Director • Surgeon • British • Lives in England • Born in Mar 1953
Richard James Charles Pertwee
Director • JP Retired • British • Lives in England • Born in May 1955
PSC
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
The Challenge Hub Cic
Richard James Charles Pertwee is a mutual person.
Dissolved
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Dec ⟶ 31 Dec 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£0
Same as previous period
Total Liabilities
£0
Same as previous period
Net Assets
£0
Same as previous period
Debt Ratio (%)
Unreported
See 10 Year Full Financials
Latest Activity
Confirmation Submitted
1 Month Ago on 25 Sep 2025
Full Accounts Submitted
4 Months Ago on 26 Jun 2025
Richard James Charles Pertwee Resigned
5 Months Ago on 14 May 2025
Full Accounts Submitted
1 Year Ago on 22 Oct 2024
Confirmation Submitted
1 Year 1 Month Ago on 26 Sep 2024
Mr Richard James Charles Pertwee Details Changed
2 Years Ago on 5 Oct 2023
Paul Adam Reynolds Resigned
2 Years Ago on 5 Oct 2023
Confirmation Submitted
2 Years Ago on 5 Oct 2023
Ms Asha Senapati Details Changed
2 Years Ago on 5 Oct 2023
Full Accounts Submitted
2 Years 1 Month Ago on 4 Oct 2023
Get Alerts
Get Credit Report
Discover Bowel & Cancer Research's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Termination of appointment of Richard James Charles Pertwee as a director on 14 May 2025
Submitted on 25 Sep 2025
Confirmation statement made on 23 September 2025 with no updates
Submitted on 25 Sep 2025
Total exemption full accounts made up to 31 December 2024
Submitted on 26 Jun 2025
Total exemption full accounts made up to 31 December 2023
Submitted on 22 Oct 2024
Confirmation statement made on 23 September 2024 with no updates
Submitted on 26 Sep 2024
Director's details changed for Ms Asha Senapati on 5 October 2023
Submitted on 5 Oct 2023
Confirmation statement made on 23 September 2023 with no updates
Submitted on 5 Oct 2023
Termination of appointment of Paul Adam Reynolds as a director on 5 October 2023
Submitted on 5 Oct 2023
Director's details changed for Mr Richard James Charles Pertwee on 5 October 2023
Submitted on 5 Oct 2023
Total exemption full accounts made up to 31 December 2022
Submitted on 4 Oct 2023
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs